Constellation Energy and Option Care Health Surge Premarket on Google Power Deal and Takeover Report

3 min read
Constellation Energy and Option Care Health Surge Premarket on Google Power Deal and Takeover Report
PrimeXBT Editorial Team
Reviewed by PrimeXBT

Topics in article

Several S&P 500 components swung sharply before Tuesday's opening bell. A nuclear power supply deal lifted Constellation Energy and Alphabet, a takeover report sent Option Care Health up more than 20%, and fresh analyst calls moved AMD, Procter & Gamble and Corteva.

Two S&P 500 components led the stock market's premarket gainers on Tuesday: Constellation Energy and Option Care Health, each jumping on separate corporate news, while a cluster of analyst upgrades pushed several other large-cap names higher ahead of the open.

Google's nuclear deal lifts Constellation Energy

Constellation Energy jumped more than 6% premarket after Alphabet announced a long-term power agreement with the utility. Google will buy power tied to 890 megawatts of new nuclear capacity, alongside a separate 2,700-megawatt supply agreement, supporting more than $4.3 billion in new Constellation investment. Alphabet shares themselves rose about 0.5% on the news.

Option Care Health jumps on takeover report

Option Care Health shares surged more than 20% after the Financial Times reported that McKesson and private equity firm Clayton Dubilier & Rice are in advanced talks to jointly acquire the infusion-services provider. The deal under discussion is valued at more than $5 billion. McKesson stock itself rose 1.5% on the report.

Berkshire builds a Lennar stake, NeoGenomics names new leadership

In a regulatory filing, Berkshire Hathaway disclosed it purchased about 2.4 million shares of Lennar, sending Lennar shares up 1.5% while Berkshire was fractionally higher. NeoGenomics shares rose 5% after the company announced that President and COO Warren Stone will take the helm from Tony Cook in January 2027. The company also flagged preliminary third-quarter revenue of $209 million, topping the $205.9 million consensus estimate, per FactSet.

Analyst calls move AMD, P&G and Corteva

AMD rose nearly 2% after Citi raised its price target to $800, signaling more than 26% upside from Monday's close, pointing to greater CPU demand driven by Meta's Muse AI agent. According to CNBC, Citi said: "AMD will be the primary beneficiary of the CPU renaissance."

Procter & Gamble shares rose 1.2% after Evercore ISI upgraded the stock to outperform and raised its price target to $166 from $161, implying about 14% upside from Monday's close. Corteva shares climbed nearly 3% after JPMorgan upgraded the stock to overweight, with a $19 price target implying 53% upside, citing a sharper focus on crop chemicals and improving agricultural commodity prices.

Source: US Top News and Analysis

Trading involves risk.

Most traded markets

XAU / USD
+0.68% 4,168.35
BRENT
-2.53% 100.763
BTC / USD
+0.06% 86,087.7
EUR / USD
+0.33% 1.12601
USTEC
+0.55% 31,260.48
NVDA
+0.57% 241.32
View all markets

Author

PrimeXBT
Our Editorial Team consists of leading experts with a proven record in the fields of trading, cryptocurrencies, blockchain and finance. We thoroughly research the sources of information in order to provide readers with quality content that serves edu...
Read author’s articles
Alert Triangle Risk Disclaimer
Disclaimer: Some past publications may be outdated. We recommend following our news to stay up to date with the latest information. For any questions, feel free to contact our support team via the chat below.
The content provided here is for informational purposes only. It is not intended as personal investment advice and does not constitute a solicitation or invitation to engage in any financial transactions, investments, or related activities. Past performance is not a reliable indicator of future results.
The financial products offered by the Company are complex and come with a high risk of losing money rapidly due to leverage. These products may not be suitable for all investors. Before engaging, you should consider whether you understand how these leveraged products work and whether you can afford the high risk of losing your money.
The Company does not accept clients from the Restricted Jurisdictions as indicated in our website/ T&C. Some services or products may not be available in your jurisdiction.
The applicable legal entity and its respective products and services depend on the client’s country of residence and the entity with which the client has established a contractual relationship during registration.

Today in markets

Browse Indices News

Register Now

Trading involves risk

Get started in minutes

Our clients love how fast and simple our sign-up is. It takes just a few minutes to get started!

Get Started Get Started
Get started in minutes

Need Help?

Risk Warning:
Trading in leveraged products carries a high level of risk and may not be suitable for all investors.